Browse Drug Recalls
6,306 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 6,306 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 6,306 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Mar 20, 2013 | Medroxyprogesterone 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 ... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Estradiol Valerate 20 mg/ml, Clinical Specialties Compounding Pharmacy, 318 B... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Test Cyp 25 mg-e(2) blend 12 mg/ml, Clinical Specialties Compounding Pharmacy... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Test Cyp 50 mg-estradiol cyp 7 mg/ml, Clinical Specialties Compounding Pharma... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Tetracaine(buffered) 0.25% solution, Clinical Specialties Compounding Pharmac... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Acetylcysteine 2 % Solution, Clinical Specialties Compounding Pharmacy, 318 ... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Acetylcysteine 10 % Solution, Clinical Specialties Compounding Pharmacy, 318 ... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Gentamicin buffered 36.4 mg/ml, Clinical Specialties Compounding Pharmacy, 31... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Diazepam 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road,... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Medroxyprogesterone 150 mg/ml,Clinical Specialties Compounding Pharmacy, 318 ... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Methionine/Choline/Inositol/ B-12, Clinical Specialties Compounding Pharmacy,... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Latanoprost 0.025% eye drop, Clinical Specialties Compounding Pharmacy, 318 B... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Estradiol Valerate 30 mg/ml, Clinical Specialties Compounding Pharmacy, 318 B... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Estradiol Cypionate 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 B... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Hydroxyprogesterone 250 mg/ml, Clinical Specialties Compounding Pharmacy, 318... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Pap 300 mg-phent 10 mg-prost 100 mcg, Clinical Specialties Compounding Pharma... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Acetylcysteine 20 % solution, 100 ml bottle, Clinical Specialties Compounding... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Test cyp 25 mg-estradiol cyp 7 mg/ml, Clinical Specialties Compounding Pharma... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Test Cyp 10 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Test Cyp 100 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Roa... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Test Cyp 200 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Roa... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Laser ophthalmic drops, 12 mL bottle, Clinical Specialties Compounding Pharma... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Cataract drops, Clinical Specialties Compounding Pharmacy, 318 Baston Road, A... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Cyclosporine 2% ophthalmic, Clinical Specialties Compounding Pharmacy, 318 Ba... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Test cyp 25 mg-Estadiol valerate 15 mg/mL, Clinical Specialties Compounding P... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Test cyp 75 mg-estradiol cyp 5 mg/ml, Clinical Specialties Compounding Pharma... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Cyclosporine 1% ophthalmic drops, Clinical Specialties Compounding Pharmacy, ... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | HCG 1000 units/ml, 30 mL syringe, Clinical Specialties Compounding Pharmacy, ... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Test cyp 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | HCG 500 units/ml, 10 mL syringe, Clinical Specialties Compounding Pharmacy, 3... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Test cyp 25 mg-Estradiol cyp 5 mg/ml, Clinical Specialties Compounding Pharma... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Test Cyp 50 mg-estradiol cyp 2 mg/ml, Clinical Specialties Compounding Pharma... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Test Cyp 250 mg-lidocaine 5 mg/ml, Clinical Specialties Compounding Pharmacy,... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Itraconazole 1% eye ointment, Clinical Specialties Compounding Pharmacy, 318 ... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | HCG 2000 units/ml, 30 mL syringe, Clinical Specialties Compounding Pharmacy, ... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Test Cyp 50 mg-estradiol cyp 2 mg/ml, Clinical Specialties Compounding Pharma... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 20, 2013 | Test cyp 35 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 14, 2013 | Magnesium Sulfate 2 grams in Dextrose 5% for Injection, in 50 mL Plastic Infu... | Non-Sterility; mold contamination | Class I | Med Prep Consulting, Inc. |
| Mar 14, 2013 | All Compounded Products, packaged in plastic infusion bags, devices, syringes... | Lack of Assurance of Sterility; potential for mold contamination | Class II | Med Prep Consulting, Inc. |
| Mar 11, 2013 | Avastin, (0.05 ml, 1.25 mg/0.05ml), single unit dose syringes, Clinical Speci... | Lack of Assurance of Sterility; product linked to adverse event reports of endophthalimitis eye i... | Class II | Clinical Specialties Compounding Pharmacy |
| Mar 4, 2013 | SEPP 10% Povidone Iodine Solution USP (1% available Iodine, Surfactant & USP ... | Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... | Class II | CareFusion 213, LLC |
| Mar 4, 2013 | Donor Prep Kit containing 1 FREPP (70% isopropyl alcohol), Net 1.1 mL and 1 S... | Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... | Class II | CareFusion 213, LLC |
| Mar 4, 2013 | SEPP 70% Isopropanol (isopropyl alcohol) 70% v/v, USP, 200-count applicators ... | Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... | Class II | CareFusion 213, LLC |
| Mar 4, 2013 | FREPP/SEPP Kit containing 1 FREPP (povidone iodine 2% aqueous solution), Net ... | Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... | Class II | CareFusion 213, LLC |
| Mar 4, 2013 | SEPP 2% Iodine Tincture USP (47% v/v Ethyl Alcohol, 2% w/v Iodine, USP, Sodiu... | Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... | Class II | CareFusion 213, LLC |
| Mar 4, 2013 | Blood Culture Prep Kit II containing 1 FREPP (70% isopropyl alcohol), Net 1.1... | Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile... | Class II | CareFusion 213, LLC |
| Feb 26, 2013 | Diazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial, RX only, ... | Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. | Class II | Hospira Inc. |
| Feb 26, 2013 | Furosemide Injection, USP, 40 mg/4mL (10 mg/mL), 4 ml Single-Dose Vial, Rx on... | Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. | Class II | Hospira Inc. |
| Feb 26, 2013 | QUELICIN (succinylcholine chloride) Injection, USP, 200 mg (20 mg/mL) 10 mL, ... | Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. | Class II | Hospira Inc. |
| Feb 26, 2013 | Sodium Acetate Injection, USP, 40 mEq/20 ml (2 mEq/mL) 20 mL Single-Dose Flip... | Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. | Class II | Hospira Inc. |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.